Sygen ORx Biosciences Takes Center Stage on Arise News!
We’re excited to share that Sygen ORX Biosciences was recently featured on Business Week on Arise News, where Prof. Alexander Macgregor (Chairman and CSO, ORx) and Charles Ogunwuyi (CEO, Sygen) showcased how they’re transforming Nigeria’s pharmaceutical landscape via the JV.
Key Strategic Insights from the Feature:
- Addressing Critical Drug Shortages: With multinational pharmaceutical firms scaling back operations in Nigeria, Sygen ORx Biosciences is prioritizing domestic production and R&D investments to ensure consistent access to essential medicines.
- Tailored Healthcare Solutions: Leveraging pharmacogenetics, the team aims to develop medications optimized for African populations, enhancing treatment efficacy and patient outcomes.
- Boosting Local Manufacturing Capacity: By expanding domestic production capabilities, the initiative reduces reliance on imported drugs and mitigates risks associated with counterfeit pharmaceuticals.
This initiative highlights the shift from import dependence to local innovation, paving the way for a stronger and more self-sufficient pharmaceutical industry in Nigeria.
